rs186571865

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_006269.2(RP1):​c.616-6T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00608 in 1,614,088 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0044 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0062 ( 36 hom. )

Consequence

RP1
NM_006269.2 splice_region, intron

Scores

2
Splicing: ADA: 0.0002528
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:7

Conservation

PhyloP100: 1.63

Publications

0 publications found
Variant links:
Genes affected
RP1 (HGNC:10263): (RP1 axonemal microtubule associated) This gene encodes a member of the doublecortin family. The protein encoded by this gene contains two doublecortin domains, which bind microtubules and regulate microtubule polymerization. The encoded protein is a photoreceptor microtubule-associated protein and is required for correct stacking of outer segment disc. This protein and the RP1L1 protein, another retinal-specific protein, play essential and synergistic roles in affecting photosensitivity and outer segment morphogenesis of rod photoreceptors. Because of its response to in vivo retinal oxygen levels, this protein was initially named ORP1 (oxygen-regulated protein-1). This protein was subsequently designated RP1 (retinitis pigmentosa 1) when it was found that mutations in this gene cause autosomal dominant retinitis pigmentosa. Mutations in this gene also cause autosomal recessive retinitis pigmentosa. Transcript variants resulted from an alternative promoter and alternative splicings have been found, which overlap the current reference sequence and has several exons upstream and downstream of the current reference sequence. However, the biological validity and full-length nature of some variants cannot be determined at this time.[provided by RefSeq, Sep 2010]
RP1 Gene-Disease associations (from GenCC):
  • RP1-related dominant retinopathy
    Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen
  • retinitis pigmentosa 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • RP1-related recessive retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 8-54622111-T-C is Benign according to our data. Variant chr8-54622111-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 196435.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00443 (674/152302) while in subpopulation AMR AF = 0.00713 (109/15298). AF 95% confidence interval is 0.00637. There are 5 homozygotes in GnomAd4. There are 306 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD,SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RP1NM_006269.2 linkc.616-6T>C splice_region_variant, intron_variant Intron 2 of 3 ENST00000220676.2 NP_006260.1 P56715

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RP1ENST00000220676.2 linkc.616-6T>C splice_region_variant, intron_variant Intron 2 of 3 1 NM_006269.2 ENSP00000220676.1 P56715
RP1ENST00000637698.1 linkc.616-6T>C splice_region_variant, intron_variant Intron 2 of 28 5 ENSP00000490104.1 A0A1B0GUH0
RP1ENST00000636932.1 linkc.616-6T>C splice_region_variant, intron_variant Intron 2 of 22 5 ENSP00000489857.1 A0A1B0GTV9

Frequencies

GnomAD3 genomes
AF:
0.00442
AC:
672
AN:
152184
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00707
Gnomad ASJ
AF:
0.00547
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00687
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00505
AC:
1269
AN:
251374
AF XY:
0.00481
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.00735
Gnomad ASJ exome
AF:
0.00665
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000785
Gnomad NFE exome
AF:
0.00747
Gnomad OTH exome
AF:
0.00783
GnomAD4 exome
AF:
0.00625
AC:
9132
AN:
1461786
Hom.:
36
Cov.:
32
AF XY:
0.00600
AC XY:
4366
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.00128
AC:
43
AN:
33478
American (AMR)
AF:
0.00771
AC:
345
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00662
AC:
173
AN:
26128
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000290
AC:
25
AN:
86252
European-Finnish (FIN)
AF:
0.00176
AC:
94
AN:
53418
Middle Eastern (MID)
AF:
0.0163
AC:
94
AN:
5756
European-Non Finnish (NFE)
AF:
0.00721
AC:
8019
AN:
1111942
Other (OTH)
AF:
0.00560
AC:
338
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
439
877
1316
1754
2193
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00443
AC:
674
AN:
152302
Hom.:
5
Cov.:
32
AF XY:
0.00411
AC XY:
306
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.00130
AC:
54
AN:
41580
American (AMR)
AF:
0.00713
AC:
109
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00547
AC:
19
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4816
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00688
AC:
468
AN:
68012
Other (OTH)
AF:
0.00473
AC:
10
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
30
60
91
121
151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00567
Hom.:
3
Bravo
AF:
0.00514
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00632
EpiControl
AF:
0.00818

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RP1: BS1, BS2 -

Retinitis pigmentosa Pathogenic:1Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 01, 2015
NIHR Bioresource Rare Diseases, University of Cambridge
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

not specified Benign:1
Dec 19, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa 1 Benign:1
Oct 13, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
6.6
DANN
Benign
0.91
PhyloP100
1.6
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00025
dbscSNV1_RF
Benign
0.028
SpliceAI score (max)
0.26
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.26
Position offset: 6

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs186571865; hg19: chr8-55534671; COSMIC: COSV55120718; API